VIM and cancer: Nonetheless, while phosphorylation by several tyrosine kinases and SUMO 2/3 modifications of vimentin plays a key role in promoting cell growth and migration, mechanisms and pathophysiological consequences of SUMOylation, O-linked glycosylation, and other PTMs in cancers remain poorly understood [44,47,48,49].